Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)

Hong You; Fusheng Wang; Taisheng Li; Xiaoyuan Xu; Yameng Sun; Yuemin Nan; Guiqiang Wang; Jinlin Hou; Zhongping Duan; Lai Wei; Jidong Jia; Hui Zhuang; Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association

doi:10.14218/JCTH.2023.00320

Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)

J Clin Transl Hepatol. 2023 Nov 28;11(6):1425-1442. doi: 10.14218/JCTH.2023.00320. Epub 2023 Aug 15.

Affiliations

¹ Beijing Friendship Hospital, Capital Medical University, Beijing, China.
² The Fifth Medical Center of PLA General Hospital, Beijing, China.
³ Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
⁴ Peking University First Hospital, Beijing, China.
⁵ Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
⁶ Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
⁷ Beijing You-An Hospital, Capital Medical University, Beijing, China.
⁸ Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
⁹ Peking University Health Science Center, Beijing, China.

Abstract

To facilitate the achieving of the goal of "eliminating viral hepatitis as a major public health threat by 2030" set by the World Health Organization, the Chinese Society of Hepatology together with the Chinese Society of Infectious Diseases (both are branches of the Chinese Medical Association) organized a panel of experts and updated the guidelines for prevention and treatment of chronic hepatitis B in China (version 2022). With the support of available evidence, this revision of the guidelines focuses on active prevention, large scale testing, and expansion of therapeutic indication of chronic hepatitis B with the aim of reducing the hepatitis B related disease burden.

Keywords: Chronic hepatitis B; Guideline; Prevention; Treatment.